← Back to Clinical Trials
Recruiting NCT07343752

NCT07343752 To Evaluate the Efficiency and Results of Adding BFR to the Physical Therapy Program fo Managing Adolescents Presented With Spasmotic Flatfoot Deformities Compared to the Standard Physical Therapy Program Without BFR

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07343752
Status Recruiting
Phase
Sponsor Assiut University
Condition Flat Foot; Spastic
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-08-18
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
blood flow restriction

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-08-18 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this randomized clinical trial is to evaluate the efficiency and results of adding blood flow restriction (BFR) training to the physical therapy program for managing adolescents presented with spasmotic flatfoot deformities compared to the Standard physical therapy program without blood flow restriction.

Eligibility Criteria

Inclusion Criteria: * Adolescents presented with idiopathic, rigid, spasmodic flatfeet. * Age should be younger than 18 years old. 3- Patients who did not respond to initial medical treatment for three weeks. Exclusion Criteria: * generalised tarsal arthritis * neurological disorder. * secondary rigid flatfoot deformity * patients who did not complete the follow up or evaluation protocol * Patients who will refuse to participate

Frequently Asked Questions

Who can join the NCT07343752 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Flat Foot; Spastic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07343752 currently recruiting?

Yes, NCT07343752 is actively recruiting participants. Visit ClinicalTrials.gov or contact Assiut University to inquire about joining.

Where is the NCT07343752 trial being conducted?

This trial is being conducted at Asyut, Egypt.

Who is sponsoring the NCT07343752 clinical trial?

NCT07343752 is sponsored by Assiut University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology